Psychedelics Today cover image

PT572 – The Potential of Buprenorphine, the Risks of Ketamine, and How Psychedelics Could Prevent Nuclear War, with Howard Kornfeld, MD

Psychedelics Today

CHAPTER

Buprenorphine and MDMA: Therapeutic Potential and Approval Challenges

This chapter explores the properties of buprenorphine as a long-acting opioid that effectively alleviates withdrawal symptoms with reduced addiction risks. It contrasts this with the challenges faced by MDMA in therapeutic settings, particularly concerning its regulatory approval and biases in research. The discussion emphasizes the discrepancies between subjective participant experiences and regulatory expectations, advocating for a more nuanced understanding of these substances' therapeutic potentials.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner